M&A partner Lauren Boehmke commented in an article in Agenda on the uptick in boards instituting shareholder rights plans, also known as “poison pills,” to protect the company from takeover attempts in light of a slowdown in the market and rising inflation.
“It’s an important tool that might come into play in a market like this, but at the end of the day, boards have to remember that you’re only going to be considering seriously adopting a rights plan if there’s a real perceived threat to the company,” said Lauren.
Click here to read the article.
Subscribe to stay current on S&C Insights.
Sending an e-mail through this web site does not create an attorney-client relationship. You should not send us any information through this web site that you would want treated confidentially.